These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16802542)

  • 1. [Possibilities of reducing heart rate by I(f)-channel inhibitors].
    Hennersdorf MG
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():150-2. PubMed ID: 16802542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac pacemaker I(f) current and its inhibition by heart rate-reducing agents.
    DiFrancesco D
    Curr Med Res Opin; 2005 Jul; 21(7):1115-22. PubMed ID: 16004681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ivabradine: a selective If current inhibitor in the treatment of stable angina.
    Andrikopoulos G; Dasopoulou C; Sakellariou D; Tzeis S; Koulouris S; Kranidis A; Kappos K; Manolis AS
    Recent Pat Cardiovasc Drug Discov; 2006 Nov; 1(3):277-82. PubMed ID: 18221092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug insight: If inhibitors as specific heart-rate-reducing agents.
    Borer JS
    Nat Clin Pract Cardiovasc Med; 2004 Dec; 1(2):103-9. PubMed ID: 16265314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The funny current: cellular basis for the control of heart rate.
    DiFrancesco D; Borer JS
    Drugs; 2007; 67 Suppl 2():15-24. PubMed ID: 17999560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ivabradine -- the first selective sinus node I(f) channel inhibitor in the treatment of stable angina.
    Sulfi S; Timmis AD
    Int J Clin Pract; 2006 Feb; 60(2):222-8. PubMed ID: 16451297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of ivabradine-induced block of HCN1 and HCN4 pacemaker channels.
    Bucchi A; Tognati A; Milanesi R; Baruscotti M; DiFrancesco D
    J Physiol; 2006 Apr; 572(Pt 2):335-46. PubMed ID: 16484306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ivabradine: pharmacodynamic aspects of its clinical use.
    Stieber J
    Methods Find Exp Clin Pharmacol; 2008 Oct; 30(8):633-41. PubMed ID: 19088948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ivabradine -- a novel approach for heart rate lowering].
    Er F; Hoppe UC
    Dtsch Med Wochenschr; 2005 Jun; 130(24):1501-2. PubMed ID: 15942839
    [No Abstract]   [Full Text] [Related]  

  • 10. Heart rate lowering by inhibition of the pacemaker current: a new therapeutic perspective in cardiovascular disease.
    Dilaveris P; Giannopoulos G; Synetos A; Gatzoulis K; Stefanadis C
    Cardiovasc Hematol Agents Med Chem; 2006 Oct; 4(4):313-8. PubMed ID: 17073608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of the If selective channel inhibitor ivabradine in the treatment of chronic stable angina.
    Prasad UK; Gray D; Purcell H
    Adv Ther; 2009 Feb; 26(2):127-37. PubMed ID: 19259630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective pharmacological inhibition of the pacemaker channel isoforms (HCN1-4) as new possible therapeutical targets.
    Koncz I; Szél T; Jaeger K; Baczkó I; Cerbai E; Romanelli MN; Gy Papp J; Varró A
    Curr Med Chem; 2011; 18(24):3662-74. PubMed ID: 21774761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Funny channels in the control of cardiac rhythm and mode of action of selective blockers.
    DiFrancesco D
    Pharmacol Res; 2006 May; 53(5):399-406. PubMed ID: 16638640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pacemaker channels and sinus node arrhythmia.
    Stieber J; Hofmann F; Ludwig A
    Trends Cardiovasc Med; 2004 Jan; 14(1):23-8. PubMed ID: 14720471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preserved Autonomic Cardiovascular Regulation With Cardiac Pacemaker Inhibition: A Crossover Trial Using High-Fidelity Cardiovascular Phenotyping.
    Heusser K; Tank J; Brinkmann J; Schroeder C; May M; Großhennig A; Wenzel D; Diedrich A; Sweep FC; Mehling H; Luft FC; Jordan J
    J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26764413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing elevated heart rate in patients with multiple organ dysfunction syndrome by the I (f) (funny channel current) inhibitor ivabradine : MODI (f)Y trial.
    Nuding S; Ebelt H; Hoke RS; Krummenerl A; Wienke A; Müller-Werdan U; Werdan K
    Clin Res Cardiol; 2011 Oct; 100(10):915-23. PubMed ID: 21638157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. I(f) inhibition in cardiovascular diseases.
    Thollon C; Vilaine JP
    Adv Pharmacol; 2010; 59():53-92. PubMed ID: 20933199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular regulation and pharmacology of pacemaker channels.
    Bois P; Guinamard R; Chemaly AE; Faivre JF; Bescond J
    Curr Pharm Des; 2007; 13(23):2338-49. PubMed ID: 17692005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of reducing heart rate in cardiovascular diseases: effects of Ivabradine.
    Vizzardi E; Bonadei I; D'Aloia A; Del Magro F; Piovanelli B; Bontempi L; Curnis A; Dei Cas L
    Minerva Med; 2011 Oct; 102(5):373-9. PubMed ID: 22193347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Physiology and pharmacology of the cardiac pacemaker ("funny") current.
    Baruscotti M; Bucchi A; Difrancesco D
    Pharmacol Ther; 2005 Jul; 107(1):59-79. PubMed ID: 15963351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.